Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3 - Wikidata - awgldk - TriplyDB

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

http://www.wikidata.org/entity/Q27477554

about

Hepatitis C virus infection protein network Hepatitis C virus and type 2 diabetes Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseases Hepatitis C Virus, Insulin Resistance, and Steatosis Hepatitis C and insulin action: An intimate relationship Hepatitis C virus infection and type 1 and type 2 diabetes mellitus SOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokines Review article: HCV genotype 3 – the new treatment challenge Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C Fatty liver in chronic hepatitis C infection: unravelling the mechanisms Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog Targeting host factors: A novel rationale for the management of hepatitis C virus Molecular mechanisms of insulin resistance in chronic hepatitis C Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini Review MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3 Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders Association of hepatitis C virus with insulin resistance: evidences from animal studies and clinical studies The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients.Constitutive expression of insulin receptor substrate (IRS)-1 inhibits myogenic differentiation through nuclear exclusion of Foxo1 in L6 myoblasts Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway.Production and pathogenicity of hepatitis C virus core gene products.Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial Hepatitis C virus associated glomerulopathies.Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization Mechanisms and significance of liver steatosis in hepatitis C virus infection Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.Adenovirus infection results in alterations of insulin signaling and glucose homeostasis.Short communication: serum-based assay accurately detects single nucleotide polymorphisms of IL28B and SOCS3 in HIV/hepatitis C virus-coinfected subjects.Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C.On-site Basic Health Screening and Brief Health Counseling of Chronic Medical Conditions for Veterans in Methadone Maintenance Treatment Toll-like receptors in the pathogenesis of alcoholic liver disease.SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases.Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis.Association of metabolic syndrome with development of new-onset diabetes after transplantation.Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytes."Second hit" models of alcoholic liver disease.

P2860

Q24311906-DD14283B-C266-443D-9263-8E3B13C9BB43 Q24658049-7C7CFD67-311F-4CC8-B605-5B7BA66296BC Q24814157-C90B05AC-39D0-4FE9-8490-B7363A8BA5CF Q26751755-21D48CA8-CCF3-41BC-889A-E24DCA265B90 Q26775000-608C399A-1FB6-4B05-B107-CB5811222FAA Q26829202-516C63BB-FA78-4F9B-8DAF-66884B9BE26F Q26853718-8B60653E-2452-4208-B5B9-8E4D470CB515 Q26864571-E842035E-6892-4F9B-AFB5-2C44BE05E2DA Q27478298-1984D09B-1A5C-4BE7-B115-1FEA3DB01130 Q27481041-82B769A8-1B49-4F22-8F9D-EF03ED58B89B Q27487860-04CF8BF9-A505-4350-BAFD-630F220D3990 Q27488999-F318E621-6414-4429-AA71-185499126B1A Q27489665-57400A39-826A-4BC0-9C5C-15A58677EEB4 Q28068362-B57A0199-FFAE-472B-95D1-C44482F043AF Q28589862-5A58800B-7867-4A07-A267-54A0C1A3EA57 Q28732828-B7153698-6E44-43E3-A431-821695432D80 Q30360538-30EC1C2D-0A21-42A1-9779-4C1499F78858 Q30369757-23CD3B16-C16E-4978-B36D-97D06BAE206A Q30395601-2B5BC2F1-8C05-4718-A7FB-8ADF9A8EC361 Q30485410-0B58C601-FAC3-43AC-8F23-BE48F94CD3FF Q30870794-6B9C1D61-AC92-4FF6-BA17-D9CA776F95B8 Q31032454-2945FEA0-1303-4064-8B8D-A29869046841 Q33618390-F5E1CA0F-6512-472E-BE54-123C512B329F Q33780095-A706CE88-E220-4883-AEA1-E3FDEA3C7DFC Q33798375-6EA71D39-5B44-4B1C-99C2-F33A3436BBDC Q33801278-46B5EA0A-2DBD-429C-8681-DC2347AA1CB5 Q33812148-D76EF758-31B0-4CA0-A234-90D1C4762887 Q33866272-C8B08018-3535-4742-91C3-DF493822C6C3 Q33877539-8C0EF709-F08A-433D-AD0E-97C8C7B11429 Q33916572-9738A76C-4BF4-465E-8B7C-1A206DB57420 Q33988201-C109CA1C-C857-48E0-BBC2-FCC7A0B17D49 Q34036689-4BBA09BC-4576-4103-A69D-742D832A9957 Q34093399-53B8EBCE-1297-466B-A9C9-97BA51B8C84B Q34106192-B81E6842-990A-47DD-96A3-2AFC06C7F25C Q34127568-ACC78CBC-8F44-424A-8070-13C831D110B9 Q34130371-30FA4849-CB68-4E93-82CA-0ED34C83BE13 Q34135004-C1B893C8-DCF8-460F-B157-86D9A16BDA34 Q34222283-D6091481-BB16-4A73-84A9-2A834FC84D13 Q34312988-A56FD93F-E5F6-47B6-BF5F-37ED9AD87136 Q34342131-F82F387D-E2F9-418C-972A-8671C6ADD8F8

P2860

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

http://www.wikidata.org/entity/Q27477554

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@ast

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@en

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@nl

type

label

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@ast

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@en

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@nl

prefLabel

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@ast

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@en

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@nl

P1433

Q27477554-9B1D271E-6930-417F-B5FD-DC0FA51DE44C

P1476

Q27477554-88D2B10C-6395-4558-BD5F-018F9EA2C9C8

P2093

Q27477554-17D041FA-74FA-4B58-B071-5F8CCC606719

Q27477554-1981B037-CD9C-406A-9B8E-B0E726A38400

Q27477554-1D894A40-012C-471E-B564-9E38C0E3252A

Q27477554-3557458D-C5A7-4B57-92D5-B40C07C4CD09

Q27477554-49ABBFA6-C24F-407D-86A2-A935DCF608C9

Q27477554-684D6493-D4D3-4A62-ACF3-9AC8EB0B9692

Q27477554-759B61CD-18D3-41F6-B936-0B7E32A0D1CA

Q27477554-87ACF6B3-F2ED-4A87-912C-69EFAA7EC4AD

Q27477554-AE41A9BA-57AE-4703-A7DC-151C15B49575

Q27477554-B48AF79D-FF14-47F0-9C89-6A1D15F2C9D6

P2860

Q27477554-018E0303-3749-4F95-ACDA-F80F0C83331E

Q27477554-028234C8-EB54-4958-A430-DA443F94646E

Q27477554-082AD6BC-7E4E-451E-ADE3-869BF7963095

Q27477554-183567D2-6D17-4E2E-A53E-D8CD333387A4

Q27477554-1D8E26FF-D829-4297-88A2-BE72F2E9E95E

Q27477554-30151643-421B-41C7-A046-FE83C5A2658A

Q27477554-3D8E532E-A94F-4ABD-917D-E681AC0B1EBC

Q27477554-4172DFD5-615F-4AFD-B263-7A7FA50CF6AB

Q27477554-4305B6FC-3A04-4359-B530-A67C2C0108FD

Q27477554-4902E6DC-C2AE-42B4-9294-C6F6418A70F3

P304

Q27477554-7BC844AF-62C7-414C-9BF2-392E4E31D8E7

P31

Q27477554-3C8D7966-60B6-49BC-BE15-FF1085381503

P3181

Q27477554-FDFCA021-D5BD-4A58-B700-B2F80728E85F

P356

Q27477554-658DAB7B-E5A6-4143-BDB2-8CE507BCBC19

P407

Q27477554-269C583C-C4C4-4D17-A39E-B5130DC26546

P433

Q27477554-C8731457-264B-49A9-9EB6-0B7BD7725160

P478

Q27477554-5DB8BC53-656E-427B-8A74-1322B4B600E2

P577

Q27477554-BB5208C2-42FF-4069-AE27-A3F523BBB597

P5875

Q27477554-06141855-089C-487D-92C0-CD47399910BF

P698

Q27477554-6E604D17-89BB-4B70-B124-2A8AD35DA791

P921

Q27477554-FD032279-6CE1-40F1-BB0B-61461E40AC05

Q27477554-FE23ED46-00DC-47D5-9BB2-661EAF9F25FA

P932

Q27477554-2A911327-0C7B-478D-A9BA-506A90B77A15

P3181

P356

S0002-9440(10)63408-6

P1433

The American Journal of Pathology

P1476

Hepatitis C Virus Down-Regulat ...... ressor of Cytokine Signaling 3

@en

P2093

Akihiko Yoshimura

http://www.w3.org/2001/XMLSchema#string

Eitaro Taniguchi

http://www.w3.org/2001/XMLSchema#string

Hironori Koga

http://www.w3.org/2001/XMLSchema#string

Hiroto Kumemura

http://www.w3.org/2001/XMLSchema#string

Hisanobu Ogata

http://www.w3.org/2001/XMLSchema#string

Masaru Harada

http://www.w3.org/2001/XMLSchema#string

Michiko Maeyama

http://www.w3.org/2001/XMLSchema#string

Michio Sata

http://www.w3.org/2001/XMLSchema#string

Ryukichi Kumashiro

http://www.w3.org/2001/XMLSchema#string

Shinichiro Hanada

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of IRS-2 causes type 2 diabetes in mice

Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

P304

1499-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1575716

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0002-9440(10)63408-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8206783

http://www.w3.org/2001/XMLSchema#string

P698

15509521

http://www.w3.org/2001/XMLSchema#string

P921

P932

1618659

http://www.w3.org/2001/XMLSchema#string